Daily Current Affairs / DCGI approves two clinical trials of indigenous Covid vaccine Corbevax
Category : National Published on: September 04 2021
· The Drug Controller General of India- DCGI has approved two clinical trials of indigenous Covid vaccine Corbevax.
· Vaccine maker Biologicals E has received permission for Phase II and III trials on children between the ages of five and eighteen under certain conditions.
· The Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council – BIRAC have provided support to Biologicals E's COVID-19 Vaccine.
· This support will be provided from the preclinical phase to the third phase of the trial.
Important facts
About the DCGI
v DCGI: Drugs Controller General of India
v Headquarters location: New Delhi
The Philippine eagle, one of the largest raptors, remains critically endangered with under 500 mature individuals.
Read More....Kannada filmmaker Joe Simon passed away at 80, leaving a legacy across 100+ films.
Read More....India will host the first International Military Adventure Challenge Cup from February 18–23 in the Eastern Himalayas.
Read More....JNCASR researchers discover wave-like heat transport in Tl₂AgI₃, challenging traditional phonon theory.
Read More....Vast partners with NASA for its sixth private astronaut mission to ISS, preparing for Haven-1 station.
Read More....India produced 33.69 million kg of wool in FY24; Rajasthan contributes nearly half of total output.
Read More....Uday Kotak appointed Chairman of GIFT City to boost India’s IFSC and global financial presence.
Read More....PM Modi will inaugurate India AI Impact Expo 2026 from 16–20 February at Bharat Mandapam.
Read More....Unani Day 2026 and National Conference concluded in Mumbai, highlighting innovation and evidence-based practice.
Read More....India launched CBDC-based Digital Food Currency pilot in Gujarat to improve transparency and efficiency in PDS.
Read More....
